Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc L Reitman

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
The American Journal of Clinical Nutrition|November 3, 2016
Reply to DS Ludwig and CB EbbelingKevin D Hall, Kong Y Chen, Juen Guo, et al.
Cell Metabolism|May 26, 2021
Preoptic BRS3 neurons increase body temperature and heart rate via multiple pathwaysRamón A Piñol, Allison S Mogul, Colleen K Hadley, et al.
Diabetes|June 28, 2003
Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasisHyunsook Kim, Martin Haluzik, Zeenat Asghar, et al.
Journal of Clinical Pharmacology|December 14, 2011
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patientsMarc L Reitman, Victor Dishy, Allison Moreau, et al.
The New England Journal of Medicine|February 22, 2002
Leptin-replacement therapy for lipodystrophyElif Arioglu Oral, Vinaya Simha, Elaine Ruiz, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonistsLiping Wang, James A Hubert, Susan J Lee, et al.
The American Journal of Clinical Nutrition|July 8, 2016
Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese menKevin D Hall, Kong Y Chen, Juen Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonistsMichael M-C Lo, Harry R Chobanian, Oksana Palyha, et al.
Diabetes|May 27, 2003
Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless miceJason K Kim, Jonathan J Fillmore, Oksana Gavrilova, et al.
Journal of Medicinal Chemistry|April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) SubstitutionDilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
The American Journal of Clinical Nutrition|November 3, 2016
Reply to DS Ludwig and CB EbbelingKevin D Hall, Kong Y Chen, Juen Guo, et al.
Cell Metabolism|May 26, 2021
Preoptic BRS3 neurons increase body temperature and heart rate via multiple pathwaysRamón A Piñol, Allison S Mogul, Colleen K Hadley, et al.
Diabetes|June 28, 2003
Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasisHyunsook Kim, Martin Haluzik, Zeenat Asghar, et al.
Journal of Clinical Pharmacology|December 14, 2011
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patientsMarc L Reitman, Victor Dishy, Allison Moreau, et al.
The New England Journal of Medicine|February 22, 2002
Leptin-replacement therapy for lipodystrophyElif Arioglu Oral, Vinaya Simha, Elaine Ruiz, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonistsLiping Wang, James A Hubert, Susan J Lee, et al.
The American Journal of Clinical Nutrition|July 8, 2016
Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese menKevin D Hall, Kong Y Chen, Juen Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonistsMichael M-C Lo, Harry R Chobanian, Oksana Palyha, et al.
Diabetes|May 27, 2003
Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless miceJason K Kim, Jonathan J Fillmore, Oksana Gavrilova, et al.
Journal of Medicinal Chemistry|April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) SubstitutionDilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
Pageof 11